Recruiting
Phase 1
Phase 2

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

Sponsor:

Cellectis S.A.

Code:

NCT05607420

Conditions

B-cell Non-Hodgkin Lymphoma (B-NHL)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

UCART20x22

CLLS52

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information